Ebola Virus

Experimental Treatment Shows Promise

Published in TB and Outbreaks Week, June 19th, 2001

An experimental treatment for Ebola virus infection using immune serum from survivors is effective in protecting mice from the disease, say researchers from the U.S. Centers for Disease Control and Prevention, Emory University, and the U.S. Army Research Institute for Infectious Diseases.

They reported their results in the May 2001 issue of the Journal of Virology.

"Our data demonstrate that it is possible to confer protection against fatal infection with Ebola virus by transfer of polyclonal immune serum," say lead author M. Gupta and colleagues ("Passive transfer of antibodies protects immunocompetent and immunodeficient mice against...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2001-06-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry